$696.64
-10.01-1.42%
Last update: Nov 10, 4:00 PM
IDEXX Laboratories Inc
IDXXNASDAQ
IDEXX Laboratories fell 0.8% from $712.47 to $706.65, behind the S&P 500's +9.8%. Its worst day was May 11 (−5.0%), and its low came Sep 11 at $504.70.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
IDEXX Laboratories closed at its highest level of the year, 7.6% above where the year started.
+1.9% · S&P 500 +0.9%
EPS of $3.08 beat the $2.93 estimate on $1.1B revenue (est. $1.1B); FY revenue guidance of $4.6B–$4.7B against the $4.7B consensus.
Story events cover the past 12 months · Times ET
−4.6% · S&P 500 +0.5%
EPS of $3.47 beat the $3.41 estimate on $1.1B revenue (est. $1.1B); FY revenue guidance of $4.7B–$4.8B against the $4.7B consensus.
0.0% · S&P 500 +0.8%
EPS of $4.27 beat the $3.94 estimate on $1.2B revenue (est. $1.2B); FY revenue guidance of $4.7B–$4.7B against the $4.7B consensus.
+3.6% · S&P 500 +1.8%
IDEXX Laboratories closed at its lowest level of the year, 29.2% below where the year started.
−0.4% · S&P 500 +0.9%
EPS of $4.01 beat the $3.71 estimate on $1.2B revenue (est. $1.2B); FY revenue guidance of $4.7B–$4.8B against the $4.7B consensus.
+21.8%, the year's best day, on 2M shares, the year's heaviest volume · S&P 500 −0.5%
Where it ended: a close of $706.65 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 1, 2027 (EPS est. $3.84, revenue est. $1.2B).
Nothing in the past 12 months.
All IDXX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IDXX and SPY from Benzinga historical bars. Not investment advice.
